Ibrutinib enhances the efficacy of ROR1 bispecific T cell engager mediated cytotoxicity in chronic lymphocytic leukaemia

BRITISH JOURNAL OF HAEMATOLOGY(2019)

引用 14|浏览17
暂无评分
关键词
chronic lymphocytic leukaemia,immunotherapy,ROR1,bispecific T cell engager,ibrutinib
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要